Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide
2. Hmr 1766
3. Hmr-1766
4. Hmr1766
1. 254877-67-3
2. Hmr-1766
3. Ataciguat [inn]
4. Hmr1766
5. Qp166m390q
6. 5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-n-(4-morpholin-4-ylsulfonylphenyl)benzamide
7. 5-chloro-2-[[(5-chloro-2-thienyl)sulfonyl]amino]-n-[4-(4-morpholinylsulfonyl)phenyl]benzamide
8. 5-chloro-2-((5-chloro-2-thienyl)sulfonylamino)-n-(4-(morpholin-4-ylsulfonyl)phenyl)benzamide
9. Dsstox_cid_28672
10. Dsstox_rid_82942
11. Dsstox_gsid_48746
12. Hmr 1766
13. Cas-254877-67-3
14. Unii-qp166m390q
15. 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide
16. Ataciguat [who-dd]
17. Schembl491675
18. Gtpl5141
19. Chembl2107729
20. Dtxsid7048746
21. Zinc3612878
22. Tox21_113203
23. Tox21_113203_1
24. Db12805
25. Sb16944
26. Ncgc00249417-01
27. Ncgc00249417-02
28. Hy-17500
29. Cs-0009242
30. Ft-0662311
31. A911275
32. J-016012
33. Q27074574
34. 5-chloro-2-(5-chlorothiophene-2-sulfonamido)-n-[4-(morpholine-4-sulfonyl)phenyl]benzamide
| Molecular Weight | 576.5 g/mol |
|---|---|
| Molecular Formula | C21H19Cl2N3O6S3 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 574.9813042 g/mol |
| Monoisotopic Mass | 574.9813042 g/mol |
| Topological Polar Surface Area | 167 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 944 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Activators
Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)
ABOUT THIS PAGE
25
PharmaCompass offers a list of Ataciguat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ataciguat manufacturer or Ataciguat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ataciguat manufacturer or Ataciguat supplier.
PharmaCompass also assists you with knowing the Ataciguat API Price utilized in the formulation of products. Ataciguat API Price is not always fixed or binding as the Ataciguat Price is obtained through a variety of data sources. The Ataciguat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ataciguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ataciguat, including repackagers and relabelers. The FDA regulates Ataciguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ataciguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ataciguat supplier is an individual or a company that provides Ataciguat active pharmaceutical ingredient (API) or Ataciguat finished formulations upon request. The Ataciguat suppliers may include Ataciguat API manufacturers, exporters, distributors and traders.
Ataciguat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ataciguat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ataciguat GMP manufacturer or Ataciguat GMP API supplier for your needs.
A Ataciguat CoA (Certificate of Analysis) is a formal document that attests to Ataciguat's compliance with Ataciguat specifications and serves as a tool for batch-level quality control.
Ataciguat CoA mostly includes findings from lab analyses of a specific batch. For each Ataciguat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ataciguat may be tested according to a variety of international standards, such as European Pharmacopoeia (Ataciguat EP), Ataciguat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ataciguat USP).
